Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fv-IgG) (CAT#: BSDG-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD89 IgG with similar domains from an anti-EGFR antibody via short peptide linkers, or vice versa. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Fv-IgG) (BSDG-132). Click the button below to contact us or submit your feedback about this product.